Walking measures to evaluate assistive technology for foot drop in multiple sclerosis: A systematic review of psychometric properties.

BACKGROUND Foot drop in people with multiple sclerosis (pwMS) often managed with assistive technologies, such as functional electrical stimulation and ankle foot orthoses. No evidence synthesis exists for the psychometric properties of outcomes used to evaluate the efficacy of these interventions. OBJECTIVE This systematic review aimed to identify the outcome measures reported to assess the benefits of assistive technology for pwMS and then synthesize the psychometric evidence in pwMS for a subset of these measures. METHODS Two searches in eight databases were conducted up to May 2017. Methodological quality was rated using the COSMIN guidelines. Overall level of evidence was scored according to the Cochrane criteria. RESULTS The first search identified 27 measures, with the 10 m walk test, gait kinematics and Physiological Cost Index (PCI) most frequently used. The second search resulted in 41 studies evaluating 10 measures related to walking performance. Strong levels of evidence were found for the internal consistency and test-retest reliability of the Multiple Sclerosis Walking Scale-12 and for the construct validity for Timed 25 Foot Walk. No psychometric studies were identified for gait kinematics and PCI in pwMS. There was a lack of evidence for measurement error and responsiveness. CONCLUSION Although a strong level of evidence exists for some measures included in this review, there was an absence of psychometric studies on commonly used measures such as gait kinematics. Future psychometric studies should evaluate a wider range of walking related measures used to assess the efficacy of interventions to treat foot drop in pwMS.

[1]  C H Polman,et al.  Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis , 2006, Multiple sclerosis.

[2]  Jaana Paltamaa,et al.  Measuring Deterioration in International Classification of Functioning Domains of People With Multiple Sclerosis Who Are Ambulatory , 2008, Physical Therapy.

[3]  A. McFadyen,et al.  The effect of functional electrical stimulation on the physiological cost of gait in people with multiple sclerosis , 2008, Multiple sclerosis.

[4]  J. Fischer,et al.  Intrarater and interrater reliability of the MS functional composite outcome measure , 2000, Neurology.

[5]  Caroline B. Terwee,et al.  Self-report fatigue questionnaires in multiple sclerosis, Parkinson’s disease and stroke: a systematic review of measurement properties , 2011, Quality of Life Research.

[6]  J. Fischer,et al.  Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. , 2001, Archives of neurology.

[7]  Richard B. Stein,et al.  A Multicenter Trial of a Footdrop Stimulator Controlled by a Tilt Sensor , 2006, Neurorehabilitation and neural repair.

[8]  S. Coote,et al.  Between-rater reliability of the 6-minute walk test, berg balance scale, and handheld dynamometry in people with multiple sclerosis. , 2013, International journal of MS care.

[9]  A. Mcgregor,et al.  Reliability and minimal detectable change of gait kinematics in people who are hypermobile. , 2016, Gait & posture.

[10]  A J Thompson,et al.  Measuring the impact of MS on walking ability , 2003, Neurology.

[11]  P. Ornetti,et al.  Test-retest reliability of 3D kinematic gait variables in hip osteoarthritis patients. , 2011, Osteoarthritis and cartilage.

[12]  C. Terwee,et al.  When to use agreement versus reliability measures. , 2006, Journal of clinical epidemiology.

[13]  Brice T Cleland,et al.  Reliability and Validity of Ratings of Perceived Exertion in Persons With Multiple Sclerosis. , 2016, Archives of physical medicine and rehabilitation.

[14]  C. Terwee,et al.  Linking measurement error to minimal important change of patient-reported outcomes. , 2009, Journal of clinical epidemiology.

[15]  Hans Kainz,et al.  Reliability of four models for clinical gait analysis. , 2017, Gait & posture.

[16]  C. Polman,et al.  Outcome measurement in multiple sclerosis: detection of clinically relevant improvement , 2010, Multiple sclerosis.

[17]  Deborah M. Miller,et al.  Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. , 2000, Archives of neurology.

[18]  Andrea Furlan,et al.  Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group , 2003, Spine.

[19]  Frances Lynn,et al.  Timed 25-Foot Walk , 2013, Neurology.

[20]  M. Gioulis,et al.  Gait analysis and clinical correlations in early Parkinson's disease. , 2017, Functional neurology.

[21]  C. Terwee,et al.  Quality criteria were proposed for measurement properties of health status questionnaires. , 2007, Journal of clinical epidemiology.

[22]  M. Mcdermott,et al.  Quantitative functional measures in MS: What is a reliable change? , 2002, Neurology.

[23]  Lorna Paul,et al.  Reliability and clinical significance of mobility and balance assessments in multiple sclerosis , 2012, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.

[24]  Enio Walker Azevedo Cacho,et al.  Gait analysis comparing Parkinson's disease with healthy elderly subjects. , 2010, Arquivos de neuro-psiquiatria.

[25]  C. Vaney,et al.  Assessing mobility in multiple sclerosis using the Rivermead Mobility Index and gait speed , 1996 .

[26]  Susan L. Kasser,et al.  Symptom variability, affect and physical activity in ambulatory persons with multiple sclerosis: Understanding patterns and time-bound relationships. , 2017, Disability and health journal.

[27]  P. Taylor,et al.  A randomized trial to investigate the effects of functional electrical stimulation and therapeutic exercise on walking performance for people with multiple sclerosis , 2009, Multiple sclerosis.

[28]  Henk J Stam,et al.  Repeatability of lower limb three-dimensional kinematics in patients with stroke. , 2008, Gait & posture.

[29]  J. Norton,et al.  The significant change for the Timed 25-Foot Walk in the Multiple Sclerosis Functional Composite , 2000, Multiple sclerosis.

[30]  L. White,et al.  Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis , 2013, Clinical rehabilitation.

[31]  Jeffrey A. Cohen,et al.  Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls , 2008, Multiple sclerosis.

[32]  E. McAuley,et al.  Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12 , 2011, Journal of the Neurological Sciences.

[33]  Roger M Enoka,et al.  Fatigue and fatigability in neurologic illnesses , 2013, Neurology.

[34]  X. Montalban,et al.  Responsiveness and predictive value of EDSS and MSFC in primary progressive MS , 2008, Neurology.

[35]  S. Gold,et al.  Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable , 2008, Multiple sclerosis.

[36]  Robert W. Motl,et al.  Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12) , 2008, Journal of the Neurological Sciences.

[37]  T. Mercer,et al.  Psychometric properties of measures of gait quality and walking performance in young people with Cerebral Palsy: A systematic review. , 2017, Gait & Posture.

[38]  T. Mercer,et al.  Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis , 2015, Disability and rehabilitation. Assistive technology.

[39]  Jeffrey A Cohen,et al.  Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects , 2012, The Lancet Neurology.

[40]  Stephen T. Holgate,et al.  Reliability: What is it, and how is it measured? , 2000 .

[41]  C. Terwee,et al.  Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist , 2011, Quality of Life Research.

[42]  G. Kwakkel,et al.  Reliability and Responsiveness of Cardiopulmonary Exercise Testing in Fatigued Persons with Multiple Sclerosis and Low to Mild Disability , 2015, PloS one.

[43]  Wolff Schlotz,et al.  Tracking daily fatigue fluctuations in multiple sclerosis: ecological momentary assessment provides unique insights , 2017, Journal of Behavioral Medicine.

[44]  J. Hobart,et al.  Kurtzke scales revisited: the application of psychometric methods to clinical intuition. , 2000, Brain : a journal of neurology.

[45]  D. Bourdette,et al.  Inter‐ and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS) , 1992, Neurology.

[46]  B. Joseph,et al.  Physiological Cost Index in Cerebral Palsy: Its Role in Evaluating the Efficiency of Ambulation , 2007, Journal of pediatric orthopedics.

[47]  John W Chow,et al.  Agreement Between Temporospatial Gait Parameters of an Electronic Walkway and a Motion Capture System in Healthy and Chronic Stroke Populations , 2009, American journal of physical medicine & rehabilitation.

[48]  V. Čapkun,et al.  Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[49]  Karen M. Schmidt,et al.  The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory , 2016, Quality of Life Research.

[50]  I. Port,et al.  Walking tests for stroke survivors: a systematic review of their measurement properties , 2012 .

[51]  Stephen M. Rao,et al.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure. , 1999, Brain : a journal of neurology.

[52]  G. Morone,et al.  Concurrent Validity of Physiological Cost Index in Walking over Ground and during Robotic Training in Subacute Stroke Patients , 2014, BioMed research international.

[53]  Peter Feys,et al.  Responsiveness and Clinically Meaningful Improvement, According to Disability Level, of Five Walking Measures After Rehabilitation in Multiple Sclerosis , 2014, Neurorehabilitation and neural repair.

[54]  F. Barkhof,et al.  Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional C omposite , 2004, Multiple sclerosis.

[55]  Robert W Motl,et al.  Further validation of multiple sclerosis walking scale-12 scores based on spatiotemporal gait parameters. , 2013, Archives of physical medicine and rehabilitation.

[56]  R. Klaren,et al.  Validity of Minimal Clinically Important Difference Values for the Multiple Sclerosis Walking Scale-12? , 2014, European Neurology.

[57]  C. Polman,et al.  A study validating changes in the multiple sclerosis functional composite. , 2002, Archives of neurology.

[58]  L. Pfalzer,et al.  Reliability of Four Functional Tests and Rating of Perceived Exertion in Persons with Multiple Sclerosis , 2006 .

[59]  B. Sharrack,et al.  The psychometric properties of clinical rating scales used in multiple sclerosis. , 1999, Brain : a journal of neurology.

[60]  C. Terwee,et al.  Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments , 2009, Quality of Life Research.

[61]  C. Terwee,et al.  The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study , 2010, Quality of Life Research.

[62]  V de Groot,et al.  Community walking can be assessed using a 10-metre timed walk test , 2011, Multiple sclerosis.

[63]  F. Bethoux,et al.  Evaluating walking in patients with multiple sclerosis: which assessment tools are useful in clinical practice? , 2011, International journal of MS care.

[64]  J. Hobart,et al.  Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures , 2013, Multiple sclerosis.

[65]  F. Barkhof,et al.  Concurrent validity of the MS Functional Composite using MRI as a biological disease marker , 2001, Neurology.

[66]  Anat Achiron,et al.  Muscular and Gait Abnormalities in Persons With Early Onset Multiple Sclerosis , 2011, Journal of neurologic physical therapy : JNPT.

[67]  J. Paltamaa,et al.  Reliability of physical functioning measures in ambulatory subjects with MS. , 2005, Physiotherapy research international : the journal for researchers and clinicians in physical therapy.

[68]  T A Sears,et al.  The effects of experimental demyelination on conduction in the central nervous system. , 1970, Brain : a journal of neurology.

[69]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[70]  U. Dalgas,et al.  Distribution-based estimates of minimum clinically important difference in cognition, arm function and lower body function after slow release-fampridine treatment of patients with multiple sclerosis. , 2016, Multiple sclerosis and related disorders.

[71]  J. Steiner,et al.  Health and Quality of Life Outcomes , 2006 .

[72]  R. Motl,et al.  Quantifying gait impairment in multiple sclerosis using GAITRite technology. , 2011, Gait & posture.

[73]  D. Rafferty,et al.  The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis , 2015, Disability and rehabilitation. Assistive technology.

[74]  C. Lederer,et al.  Ecological Validity of Walking Capacity Tests in Multiple Sclerosis , 2015, PloS one.

[75]  Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory , 2016, Multiple sclerosis.

[76]  N. Ozaki,et al.  Measurement limit of quality-of-life questionnaires in psychiatric settings , 2010, Quality of Life Research.

[77]  Diana M Sobieraj,et al.  Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis , 2012, Current medical research and opinion.

[78]  Hans Kainz,et al.  Effects of hip joint centre mislocation on gait kinematics of children with cerebral palsy calculated using patient-specific direct and inverse kinematic models. , 2017, Gait & posture.

[79]  Inter‐ and intrarater clinician agreement on joint motion patterns during gait in children with cerebral palsy , 2017, Developmental medicine and child neurology.

[80]  R. D. de Bie,et al.  Measurement Properties of Gait-Related Outcomes in Youth With Neuromuscular Diagnoses: A Systematic Review , 2014, Physical Therapy.

[81]  C. Terwee,et al.  Inter-rater agreement and reliability of the COSMIN (COnsensus-based Standards for the selection of health status Measurement Instruments) Checklist , 2010, BMC medical research methodology.

[82]  Suzanne Halliday,et al.  Interobserver Variability of Gait Analysis in Patients With Cerebral Palsy , 2003, Journal of pediatric orthopedics.

[83]  Carlo Pozzilli,et al.  Assessing walking disability in multiple sclerosis , 2012, Multiple sclerosis.

[84]  B. Bibby,et al.  Within-day variability on short and long walking tests in persons with multiple sclerosis , 2014, Journal of Neurological Sciences.

[85]  Robert W Motl,et al.  Multiple Sclerosis Walking Scale-12 and oxygen cost of walking. , 2010, Gait & posture.

[86]  Jacob J. Sosnoff,et al.  Clinically meaningful performance benchmarks in MS , 2013, Neurology.

[87]  Robert W Motl,et al.  The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis , 2013, Multiple sclerosis.

[88]  N. Larocca.  Impact of Walking Impairment in Multiple Sclerosis , 2011, The patient.

[89]  M Hutchinson,et al.  Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12) , 2004, Neurology.